Skip to main content
    P

    PACS Group, Inc. (PACS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $49.04
    +0.72 (+1.49%)

    Market Cap: $7.67B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    PACS Group, Inc. (PACS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect PACS Group (PACS) to earn $2.62 per share in the fiscal year ending Dec 31, 2026, on revenue of $5.98B. Of 6 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy233.3%
    Buy466.7%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    6

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 8.8% and revenue estimates rise 14.4%.

    Fiscal year ending Dec 31, 2026
    $2.62
    EPS consensus, revenue $5.98B
    Fiscal year ending Dec 31, 2027
    $2.85
    EPS consensus, revenue $6.84B
    Next report
    Feb 24, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.62$2.54 to $2.844$5.98B$5.81B to $6.05B5
    Dec 31, 2027$2.85$2.68 to $3.105$6.84B$6.19B to $7.35B6

    Quarterly Estimates

    The EPS consensus rises from $0.67 for the quarter ending Dec 31, 2026 to $0.69 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.67$0.62 to $0.758$1.71B$1.62B to $1.79B8
    Mar 31, 2027$0.69$0.66 to $0.703$1.75B$1.70B to $1.79B3

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 1 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202720

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 4.0% from $2.52.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$2.62$2.50$2.51$2.52$2.52+3.9%
    Fiscal year ending Dec 31, 2027$2.85$2.74$2.73$2.71$2.71+4.9%
    Quarter ending Mar 31, 2027$0.69$0.66$0.68$0.70$0.70-1.4%

    Frequently Asked Questions About PACS

    What is the PACS stock forecast?

    Consensus analyst estimates put PACS Group's EPS at $2.62 for the fiscal year ending Dec 31, 2026, on revenue of $5.98B. The consensus rating from 6 analysts is Buy.

    How do analysts rate PACS stock?

    Of 6 analysts covering PACS Group, 2 rate it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from PACS next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.62, with estimates from $2.54 to $2.84 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.85, with estimates from $2.68 to $3.10 from 5 analysts.

    What revenue do analysts expect from PACS Group next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $5.98B, with estimates from $5.81B to $6.05B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $6.84B, with estimates from $6.19B to $7.35B.

    How many analysts cover PACS?

    6 analysts rate PACS Group stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.